Lausanne, Switzerland
Regenosca SA, a biotechnology and medical devices company headquartered in Switzerland, is pioneering innovative solutions for soft tissue repair with its technology platform, TissueSpan. Founded in 2019, the company aims to revolutionize treatment protocols in the Health Care sector, especially for conditions like urethral stricture.
The company's slogan, "Meshes for soft tissue repair," underscores its commitment to providing ready-to-use, regenerative solutions that mitigate the need for invasive tissue harvesting from patients. Regenosca's First-in-Human study validates the efficacy of their meshes, which successfully induced healing at the surgical site, demonstrating their potential as a superior alternative to current gold standard methods.
While there is no information on recent investments, Regenosca's promising technology places it strategically within the burgeoning fields of Biotechnology and Medical Devices, positioning it as an attractive prospect for venture capitalists seeking innovation in healthcare solutions.
